Epidermal growth factor receptor (EGFR) and receptor tyrosine-protein kinase 3 (ErbB3)
Epidermal growth factor receptor (EGFR) and receptor tyrosine-protein kinase 3 (ErbB3) are two well-established targets in cancer therapy. ErbB signaling is among the most frequent occasions in solid tumor development [2]. Among ErbB family, EGFR, ErbB2, and ErbB3 have already been thoroughly examined. Targeted therapies against EGFR, ErbB2, or ErbB3 are under scientific development or … [Read more…]